Home/Filings/4/0001104659-20-117798
4//SEC Filing

Andrews Kurt J. 4

Accession 0001104659-20-117798

CIK 0000722830other

Filed

Oct 22, 8:00 PM ET

Accepted

Oct 23, 5:33 PM ET

Size

6.9 KB

Accession

0001104659-20-117798

Insider Transaction Report

Form 4
Period: 2020-10-23
Andrews Kurt J.
CHIEF HUMAN RESOURCES OFFICER
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2020-10-23238,0720 total
    Common Stock (238,072 underlying)
Footnotes (1)
  • [F1]In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock ("Stock Option") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration.

Documents

1 file

Issuer

IMMUNOMEDICS INC

CIK 0000722830

Entity typeother

Related Parties

1
  • filerCIK 0001636133

Filing Metadata

Form type
4
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 5:33 PM ET
Size
6.9 KB